Follow-The-Filings

Security

Cytek Biosciences Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

7 owners 1 exit max 0.0% (Israel Englander - Millen...)

owners 7
max % 0.0%
tracked value $76M
qoq A 5 R 1 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 6,291,798 $27M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 7,475,477 $38M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 912,342 $4M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 676,700 $3M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 471,392 $2M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 260,125 $1M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 30,032 $152 hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 114,256 $577 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $193.02M $200.45M $201.49M
Gross profit $109.43M $111.11M $104.46M
Gross margin * 56.7% 55.4% 51.8%
Net income -$12.15M -$6.02M -$66.54M
Net margin * -6.3% -3.0% -33.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $392.06M $396.45M $392M
Total non-current assets * $102.4M $103.05M $69.55M
Total assets $494.46M $499.5M $461.54M
Total current liabilities $56.23M $67.66M $77.8M
Total non-current liabilities * $45.17M $36.1M $42M
Total equity $393.06M $395.74M $341.74M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $5.28M $25.38M -$4.69M
Cash from investing -$93.89M -$82.97M $10.12M
Cash from financing -$41.81M -$15.82M -$13.43M
Net change in cash -$131.87M -$68.88M -$7.89M

ownership over time

filing count by report period · click a bar for that quarter’s holders